These data collectively imply that inactivation of glomerular macrophage VLA-4 activity by AS101 and the consequent inactivation of VLA-induced caspase-1 activation could be causally connected to attenuation of CGN by the compound. The gene discussed is CASP1; the disease is childhood gender nonconformity.